Cases & Deals

MindRank develops global patent portfolio related to clinical-stage small molecule therapeutics for treatment of metabolic disorders

Client(s) MindRank AI Ltd.

Jones Day is representing MindRank AI Ltd., an artificial intelligence (AI)-powered drug discovery company, in the development of global patent portfolios related to clinical-stage small molecule therapeutics and methods for the treatment of various metabolic disorders.